Cefuroxime and Potassium Clavulanate Tablet
Generic Name |
Cefuroxime and Potassium Clavulanate |
---|---|
Strength |
250 mg + 125 mg / 500 mg + 125 mg |
Form |
Tablet |
Packaging |
1 x 6 / 1 x 10 / 1 x 14 |
Therapeutic use |
Antibiotic |
Manufacturing Period |
30 to 45 Days |
Available Composition of
Name | Strength | Therapeutic use | View More |
---|---|---|---|
Cefuroxime Injection | 1 gm, 250 mg, 500 mg, 750 mg | Antibiotic | |
Cefuroxime and Sulbactam Injection | 1 gm + 125 mg, 2 gm + 250 mg | Antibiotic | |
Cefuroxime and Potassium Clavulanate Tablet | 250 mg + 125 mg, 500 mg + 125 mg | Antibiotic | |
Cefpodoxime and Potassium Clavulanate Tablet | 200 mg + 125mg | Antibiotic | |
Amoxicillin and Potassium Clavulanate Tablet | 250 mg + 125 mg, 500 mg + 125 mg, 875 mg + 125 mg | Antibiotic | |
Amoxicillin and Potassium Clavulanate Suspension | 125 mg + 31.25 mg | Antibiotic | |
Cefixime and Potassium Clavulanate Tablet | 100 mg + 62.5mg, 200 mg + 125 mg | Antibiotic | |
Amoxycillin and Potassium Clavulanate Injection | 1.2 gm, 150 mg, 300 mg, 600 mg | Antibiotic, Bacterial Infections |
Product Description For Cefuroxime and Potassium Clavulanate Tablet
products details and uses
Cefuroxime and Potassium Clavulanate Exporter India, Manufacturer, Wholesaler & Distributor
Cefuroxime is a potent antibiotic that works by inhibiting the formation of bacterial cell walls, which are essential for bacterial survival. However, some bacteria produce beta-lactamase enzymes that can deactivate Cefuroxime. Clavulanic Acid, a beta-lactamase inhibitor, counters this resistance mechanism by preventing the degradation of Cefuroxime. Together, this combination enhances the antibiotic’s effectiveness, making it highly efficient against a broader range of bacterial infections.
We are a leading manufacturer, exporter, wholesaler, and distributor of Cefuroxime and Clavulanic Acid formulations in India, supplying high-quality pharmaceutical products to domestic and international markets. Our offerings adhere to stringent quality standards and are available in various formulations to meet the needs of healthcare providers and pharmaceutical partners worldwide.
Global Distribution Network
With a strong logistics and compliance framework, we successfully export Cefuroxime and Potassium Clavulanate to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey